BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
2659 results:

  • 1. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Prabhash K; Saldanha E; Patil V; Bal M; Reddy P S; Sanjeev A; Kumar R; Poojary D; Noronha V; Menon N; Mittal N; Trivedi V; Nambiar K; Mishra R; Tanwar N; Malhotra R; Pange P; Gupta V; Veldore VH; Chougule A; Chaturvedi P; Dutt A; Chandrani P
    JCO Precis Oncol; 2024 May; 8():e2300622. PubMed ID: 38754058
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Proteostatic reactivation of the developmental transcription factor TBX3 drives braf/MAPK-mediated tumorigenesis.
    Zhang Z; Wu Y; Fu J; Yu X; Su Y; Jia S; Cheng H; Shen Y; He X; Ren K; Zheng X; Guan H; Rao F; Zhao L
    Nat Commun; 2024 May; 15(1):4108. PubMed ID: 38750011
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
    Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
    Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
    BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Molecular diagnostics enable targeted therapies for anaplastic and poorly differentiated thyroid cancer].
    Altena R; Nilsson M; Bergman V; Dahlberg J; Christofer Juhlin C; Zedenius J
    Lakartidningen; 2024 Feb; 121():. PubMed ID: 38712675
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
    Chen Y; Xiao X; Hu G; Liu R; Xue J
    J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic value of high-frequency ultrasound combined with fine needle aspiration cytology and braf gene for papillary thyroid microcarcinoma.
    Li C; Zhao X; Zhao J; Zhao J; An L; Wu G
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):187-191. PubMed ID: 38650135
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
    Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
    Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring braf
    Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
    Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
    Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
    Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic alterations and allele frequency of braf V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study.
    Huang J; Wang J; Xv J; Wang J; Wang G; Zhao Y
    Clin Exp Med; 2024 Apr; 24(1):76. PubMed ID: 38607456
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers.
    Wolfe AR; Feng H; Zuniga O; Rodrigues H; Eldridge DE; Yang L; Shen C; Williams TM
    Cancer Lett; 2024 Jun; 591():216873. PubMed ID: 38604313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
    Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
    J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A machine learning approach for predicting radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma undergoing tomotherapy.
    Quan KR; Lin WR; Hong JB; Lin YH; Chen KQ; Chen JH; Cheng PJ
    Sci Rep; 2024 Apr; 14(1):8436. PubMed ID: 38600141
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. braf and RET polymorphism association with thyroid cancer risk, a preliminary study from Khyber Pakhtunkhwa population.
    Batool M; Khan NU; Khan H; Almutairi MH; Ali I; Adams BD
    Mol Biol Rep; 2024 Apr; 51(1):502. PubMed ID: 38598020
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combined braf and PIM1 inhibitory therapy for papillary thyroid carcinoma based on brafV600E regulation of PIM1: Synergistic effect and metabolic mechanisms.
    Xu Q; Wang J; Mao Y; Xuan Z; Yang K; Tang X; Zhu X
    Neoplasia; 2024 Jun; 52():100996. PubMed ID: 38593698
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Correlation Between the Clinicopathological Features of Papillary thyroid Carcinoma Complicated with Hashimoto's thyroiditis, braf V600E Gene Mutation, and RET Gene Rearrangement.
    Xie M; Xu ZX; Dai M; Zhu YY
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary thyroid Microcarcinoma.
    Lim J; Lee HS; Heo JH; Song YS
    Endocrinol Metab (Seoul); 2024 Apr; 39(2):324-333. PubMed ID: 38572535
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 133.